Nicotinamide riboside kinase structures reveal new pathways to NAD+.

The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wolfram Tempel, Wael M Rabeh, Katrina L Bogan, Peter Belenky, Marzena Wojcik, Heather F Seidle, Lyudmila Nedyalkova, Tianle Yang, Anthony A Sauve, Hee-Won Park, Charles Brenner
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2007
Materias:
Acceso en línea:https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e9369
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e381eb8f8a6473f955a9c049c6e9369
record_format dspace
spelling oai:doaj.org-article:6e381eb8f8a6473f955a9c049c6e93692021-12-02T19:54:31ZNicotinamide riboside kinase structures reveal new pathways to NAD+.1544-91731545-788510.1371/journal.pbio.0050263https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e93692007-10-01T00:00:00Zhttps://doi.org/10.1371/journal.pbio.0050263https://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+.Wolfram TempelWael M RabehKatrina L BoganPeter BelenkyMarzena WojcikHeather F SeidleLyudmila NedyalkovaTianle YangAnthony A SauveHee-Won ParkCharles BrennerPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 5, Iss 10, p e263 (2007)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Wolfram Tempel
Wael M Rabeh
Katrina L Bogan
Peter Belenky
Marzena Wojcik
Heather F Seidle
Lyudmila Nedyalkova
Tianle Yang
Anthony A Sauve
Hee-Won Park
Charles Brenner
Nicotinamide riboside kinase structures reveal new pathways to NAD+.
description The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+.
format article
author Wolfram Tempel
Wael M Rabeh
Katrina L Bogan
Peter Belenky
Marzena Wojcik
Heather F Seidle
Lyudmila Nedyalkova
Tianle Yang
Anthony A Sauve
Hee-Won Park
Charles Brenner
author_facet Wolfram Tempel
Wael M Rabeh
Katrina L Bogan
Peter Belenky
Marzena Wojcik
Heather F Seidle
Lyudmila Nedyalkova
Tianle Yang
Anthony A Sauve
Hee-Won Park
Charles Brenner
author_sort Wolfram Tempel
title Nicotinamide riboside kinase structures reveal new pathways to NAD+.
title_short Nicotinamide riboside kinase structures reveal new pathways to NAD+.
title_full Nicotinamide riboside kinase structures reveal new pathways to NAD+.
title_fullStr Nicotinamide riboside kinase structures reveal new pathways to NAD+.
title_full_unstemmed Nicotinamide riboside kinase structures reveal new pathways to NAD+.
title_sort nicotinamide riboside kinase structures reveal new pathways to nad+.
publisher Public Library of Science (PLoS)
publishDate 2007
url https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e9369
work_keys_str_mv AT wolframtempel nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT waelmrabeh nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT katrinalbogan nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT peterbelenky nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT marzenawojcik nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT heatherfseidle nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT lyudmilanedyalkova nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT tianleyang nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT anthonyasauve nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT heewonpark nicotinamideribosidekinasestructuresrevealnewpathwaystonad
AT charlesbrenner nicotinamideribosidekinasestructuresrevealnewpathwaystonad
_version_ 1718375905362968576